ATE402168T1 - Heterocyclische topoisomerase toxine - Google Patents
Heterocyclische topoisomerase toxineInfo
- Publication number
- ATE402168T1 ATE402168T1 AT98965021T AT98965021T ATE402168T1 AT E402168 T1 ATE402168 T1 AT E402168T1 AT 98965021 T AT98965021 T AT 98965021T AT 98965021 T AT98965021 T AT 98965021T AT E402168 T1 ATE402168 T1 AT E402168T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- compounds
- heterocyclic
- group
- salts
- Prior art date
Links
- 101710183280 Topoisomerase Proteins 0.000 title 1
- 239000003053 toxin Substances 0.000 title 1
- 231100000765 toxin Toxicity 0.000 title 1
- 108700012359 toxins Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- -1 N(X) Chemical compound 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7028797P | 1997-12-31 | 1997-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE402168T1 true ATE402168T1 (de) | 2008-08-15 |
Family
ID=22094368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98965021T ATE402168T1 (de) | 1997-12-31 | 1998-12-30 | Heterocyclische topoisomerase toxine |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6667302B2 (enExample) |
| EP (1) | EP1044199B1 (enExample) |
| JP (1) | JP2002509858A (enExample) |
| CN (1) | CN1299358A (enExample) |
| AT (1) | ATE402168T1 (enExample) |
| AU (1) | AU753268B2 (enExample) |
| CA (1) | CA2316221A1 (enExample) |
| DE (1) | DE69839781D1 (enExample) |
| IL (1) | IL136911A0 (enExample) |
| PL (1) | PL341539A1 (enExample) |
| WO (1) | WO1999033824A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299358A (zh) * | 1997-12-31 | 2001-06-13 | 新泽西州州立大学(拉特格斯) | 杂环拓扑异构酶毒性剂 |
| BRPI0413234A (pt) * | 2003-08-01 | 2006-10-03 | Genelabs Tech Inc | derivados de imidazola bicìclica contra flaviviridae |
| CN101103026A (zh) * | 2005-01-14 | 2008-01-09 | 健亚生物科技公司 | 用于治疗病毒感染的吲哚衍生物 |
| US7998974B2 (en) | 2005-03-03 | 2011-08-16 | Sirtris Pharmaceuticals, Inc. | Fused heterocyclic compounds and their use as sirtuin modulators |
| US8088928B2 (en) | 2005-08-04 | 2012-01-03 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US7855289B2 (en) | 2005-08-04 | 2010-12-21 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US8093401B2 (en) | 2005-08-04 | 2012-01-10 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| US7345178B2 (en) | 2005-08-04 | 2008-03-18 | Sirtris Pharmaceuticals, Inc. | Sirtuin modulating compounds |
| WO2008073451A2 (en) * | 2006-12-11 | 2008-06-19 | Sirtris Pharmaceuticals, Inc. | Benzoimidazole derivatives as sirtuin (sir) modulating compounds |
| TW200916472A (en) | 2007-06-20 | 2009-04-16 | Sirtris Pharmaceuticals Inc | Sirtuin modulating compounds |
| CN102388054B (zh) | 2008-12-19 | 2015-03-04 | 西特里斯药业公司 | 噻唑并吡啶沉默调节蛋白调节剂的化合物 |
| CA2987055C (en) | 2015-05-28 | 2023-10-17 | Ecolab Usa Inc. | Purine-based corrosion inhibitors |
| EP3303324B1 (en) * | 2015-05-28 | 2021-08-25 | Ecolab USA Inc. | Novel corrosion inhibitors |
| JP6898255B2 (ja) | 2015-05-28 | 2021-07-07 | エコラボ ユーエスエー インコーポレイティド | ２−置換イミダゾール及びベンズイミダゾール腐食抑制剤 |
| EP3303655B1 (en) | 2015-05-28 | 2025-03-12 | Ecolab Usa Inc. | Water-soluble pyrazole derivatives as corrosion inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US26065A (en) * | 1859-11-08 | Improvement in cotton-gins | ||
| USRE26065E (en) | 1966-07-19 | Folybenzimidazoles and their preparation | ||
| US2985661A (en) | 1956-02-06 | 1961-05-23 | American Cyanamid Co | Preparation of 2(omicron-aminophenyl)-benzimidazole |
| CH420045A (de) | 1964-09-01 | 1967-03-15 | Ciba Geigy | Verwendung von neuen Poly-azolen als optische Aufhellmittel für textile organische Materialien |
| DE1670684A1 (de) * | 1966-04-01 | 1970-12-03 | Hoechst Ag | Verfahren zur Herstellung von basisch substituierten Bis-benzimidazol-derivaten |
| SU1530628A1 (ru) | 1987-11-20 | 1989-12-23 | Ленинградский Технологический Институт Им.Ленсовета | Тригидрохлорид 2-[2-фенил-5(6)-бензимидазолил]-N-(3-диметиламинопропил)-5(6)-бензимидазолкарбоксамида в качестве флуоресцентного красител дл исследовани ДНК |
| JP2700475B2 (ja) | 1988-07-30 | 1998-01-21 | コニカ株式会社 | 非線形光学材料および非線形光学素子 |
| US5106863A (en) | 1990-03-26 | 1992-04-21 | Ortho Pharmaceutical Corporation | Substituted imidazole and pyridine derivatives |
| US5767142A (en) | 1996-03-20 | 1998-06-16 | Rutgers, The State University Of New Jersey | Trisbenzimidazoles useful as topoisomerase I inhibitors |
| US5807874A (en) | 1995-05-17 | 1998-09-15 | Rutgers, The State University Of New Jersey | Trisbenzimidazoles useful as topoisomerase I inhibitors |
| CA2221248A1 (en) * | 1995-05-17 | 1996-11-21 | Leroy Fong Liu | Tribenzimidazoles useful as topoisomerase i inhibitors |
| US5770617A (en) * | 1996-03-20 | 1998-06-23 | Rutgers, The State University Of New Jersey | Terbenzimidazoles useful as antifungal agents |
| CN1299358A (zh) * | 1997-12-31 | 2001-06-13 | 新泽西州州立大学(拉特格斯) | 杂环拓扑异构酶毒性剂 |
| IL137351A0 (en) * | 1998-02-12 | 2001-07-24 | Univ Rutgers | Heterocyclic topoisomerase poisons |
-
1998
- 1998-12-30 CN CN98813818A patent/CN1299358A/zh active Pending
- 1998-12-30 AT AT98965021T patent/ATE402168T1/de not_active IP Right Cessation
- 1998-12-30 WO PCT/US1998/027822 patent/WO1999033824A1/en not_active Ceased
- 1998-12-30 AU AU20220/99A patent/AU753268B2/en not_active Ceased
- 1998-12-30 DE DE69839781T patent/DE69839781D1/de not_active Expired - Lifetime
- 1998-12-30 JP JP2000526506A patent/JP2002509858A/ja active Pending
- 1998-12-30 PL PL98341539A patent/PL341539A1/xx unknown
- 1998-12-30 IL IL13691198A patent/IL136911A0/xx unknown
- 1998-12-30 EP EP98965021A patent/EP1044199B1/en not_active Expired - Lifetime
- 1998-12-30 CA CA002316221A patent/CA2316221A1/en not_active Abandoned
-
2001
- 2001-06-13 US US09/869,141 patent/US6667302B2/en not_active Expired - Lifetime
-
2003
- 2003-10-21 US US10/690,800 patent/US6995154B2/en not_active Expired - Fee Related
-
2006
- 2006-01-25 US US11/339,006 patent/US20080004280A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1299358A (zh) | 2001-06-13 |
| IL136911A0 (en) | 2001-06-14 |
| US6995154B2 (en) | 2006-02-07 |
| JP2002509858A (ja) | 2002-04-02 |
| US20020151575A1 (en) | 2002-10-17 |
| DE69839781D1 (en) | 2008-09-04 |
| PL341539A1 (en) | 2001-04-23 |
| US6667302B2 (en) | 2003-12-23 |
| WO1999033824A1 (en) | 1999-07-08 |
| US20080004280A1 (en) | 2008-01-03 |
| AU2022099A (en) | 1999-07-19 |
| EP1044199B1 (en) | 2008-07-23 |
| AU753268B2 (en) | 2002-10-10 |
| US20040082637A1 (en) | 2004-04-29 |
| EP1044199A1 (en) | 2000-10-18 |
| CA2316221A1 (en) | 1999-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| EA200100983A1 (ru) | Производные 13-метилэритромицина | |
| DE69839781D1 (en) | Heterocyclische topoisomerase toxine | |
| DK1485359T3 (da) | Natriumkanalblokkere | |
| CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| MXPA04001323A (es) | Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso. | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
| TR200000059T2 (tr) | Piridin türevleri | |
| PT896533E (pt) | Pentafluorobenzenosulfonamidas e analogos | |
| PT846686E (pt) | Derivados de 1-fenil-pirazole e suas utilizacoes como agentes parasiticidas | |
| BR9801020A (pt) | Derivados de azaindol-etilamina como agentes de ligação do receptor de acetilcolina nicotìnico. | |
| ES2191260T3 (es) | Derivados de la imidazolidin-4-ona utiles como agentes anticancerosos. | |
| EA200100422A1 (ru) | Производные мононитрата изосорбида и их использование в качестве сосудорасширяющих агентов с пониженной толерантностью | |
| EE200000472A (et) | Kasvajavastased toimeained | |
| EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
| DK1000034T3 (da) | Substituerede 6-alkylphenanthridiner | |
| EP1453506A4 (en) | Topoisomerase GIFT FUNDS | |
| MX9700807A (es) | Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos. | |
| NO970340D0 (no) | Organiske forbindelser | |
| BR9713176A (pt) | Benzotiofenos amorfos,métodos de preparação e métodos de uso | |
| ATE246174T1 (de) | Tosylprolin-derivate als thymidylat-synthase inhibitoren | |
| AR027035A1 (es) | Pirroles sustituidos | |
| DE69900297D1 (de) | Akarizid und insektizid wirksame, substituierte Pyrimidine und Verfahren zu ihrer Herstellung | |
| EA200101050A1 (ru) | Замещенные бензолактамные соединения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |